A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases

The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.

Trial Details

NCT ID
NCT05564949
Phase
NA
Sponsor
Attikon Hospital
Status
RECRUITING
Cancer Type
Brain Cancer
Interventions
  • CKD
Locations (sample)
  • Chaïdári, Athens, Greece|38.01135,23.66597
  • Athens, Greece|37.98376,23.72784

Key Eligibility Criteria

  • Karnofsky Performance Score of 50 or more.
  • Newly diagnosed, histologically confirmed glioblastoma grade 4, or secondary metastases or progression after surgical resection, radiation and chem…
  • Normal function of liver and kidneys
  • Ability to sign informed consent form

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Brain Cancer Trials on Trialify →